Dexoxadrol: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Dexoxadrol}} | {{DISPLAYTITLE:Dexoxadrol}} | ||
'''Dexoxadrol''' is a [[dissociative anesthetic]] that was developed in the 1970s. It is chemically related to [[phencyclidine]] (PCP) and [[ketamine]], and it acts primarily as an [[NMDA receptor antagonist]]. | '''Dexoxadrol''' is a [[dissociative anesthetic]] that was developed in the 1970s. It is chemically related to [[phencyclidine]] (PCP) and [[ketamine]], and it acts primarily as an [[NMDA receptor antagonist]]. | ||
==Chemical structure and properties== | |||
[[File:Dioxadrol.svg|thumb|right|Chemical structure of Dexoxadrol]] | |||
Dexoxadrol is a member of the [[dioxolane]] class of compounds. Its chemical structure is characterized by a dioxolane ring, which is a five-membered ring containing two oxygen atoms. This structure is similar to that of other dissociative anesthetics, contributing to its pharmacological effects. | |||
==Pharmacology== | ==Pharmacology== | ||
Dexoxadrol | Dexoxadrol acts as a non-competitive antagonist at the [[N-methyl-D-aspartate receptor|NMDA receptor]], which is a subtype of [[glutamate receptor]]. By blocking the NMDA receptor, dexoxadrol disrupts the normal excitatory neurotransmission mediated by [[glutamate]], leading to its anesthetic and dissociative effects. | ||
== | ===Effects=== | ||
The effects of dexoxadrol are similar to those of other dissociative anesthetics. These include: | |||
* [[Analgesia]] | |||
* [[Amnesia]] | |||
* [[Sedation]] | |||
* [[Dissociation (psychology)|Dissociation]] | |||
* [[Hallucination]] | |||
== | ==Clinical use== | ||
Dexoxadrol was investigated for use as an anesthetic agent, but it was never marketed for clinical use. Its potential for causing [[psychotomimetic]] effects and [[neurotoxicity]] limited its development as a therapeutic agent. | |||
==Research== | ==Research== | ||
Research into dexoxadrol and related compounds has provided insights into the mechanisms of | Research into dexoxadrol and related compounds has provided insights into the mechanisms of NMDA receptor antagonists and their potential therapeutic applications. Studies have explored their use in treating conditions such as [[chronic pain]], [[depression]], and [[neurodegenerative disorders]]. | ||
==Related | ==Related pages== | ||
* [[Phencyclidine]] | |||
* [[Phencyclidine]] | |||
* [[Ketamine]] | * [[Ketamine]] | ||
* [[NMDA receptor antagonist]] | * [[NMDA receptor antagonist]] | ||
* [[Dissociative | * [[Dissociative anesthetic]] | ||
[[Category:Dissociative | [[Category:Dissociative anesthetics]] | ||
[[Category:NMDA receptor antagonists]] | [[Category:NMDA receptor antagonists]] | ||
Latest revision as of 14:24, 21 February 2025
Dexoxadrol is a dissociative anesthetic that was developed in the 1970s. It is chemically related to phencyclidine (PCP) and ketamine, and it acts primarily as an NMDA receptor antagonist.
Chemical structure and properties[edit]
Dexoxadrol is a member of the dioxolane class of compounds. Its chemical structure is characterized by a dioxolane ring, which is a five-membered ring containing two oxygen atoms. This structure is similar to that of other dissociative anesthetics, contributing to its pharmacological effects.
Pharmacology[edit]
Dexoxadrol acts as a non-competitive antagonist at the NMDA receptor, which is a subtype of glutamate receptor. By blocking the NMDA receptor, dexoxadrol disrupts the normal excitatory neurotransmission mediated by glutamate, leading to its anesthetic and dissociative effects.
Effects[edit]
The effects of dexoxadrol are similar to those of other dissociative anesthetics. These include:
Clinical use[edit]
Dexoxadrol was investigated for use as an anesthetic agent, but it was never marketed for clinical use. Its potential for causing psychotomimetic effects and neurotoxicity limited its development as a therapeutic agent.
Research[edit]
Research into dexoxadrol and related compounds has provided insights into the mechanisms of NMDA receptor antagonists and their potential therapeutic applications. Studies have explored their use in treating conditions such as chronic pain, depression, and neurodegenerative disorders.
